Home - Products - Others - Other Targets - (3β,7β)-3,7,20,21-Tetrahydroxy-11,15-dioxo-lanosta-8-en-24→20 lactone

(3β,7β)-3,7,20,21-Tetrahydroxy-11,15-dioxo-lanosta-8-en-24→20 lactone

CAS No. ———

(3β,7β)-3,7,20,21-Tetrahydroxy-11,15-dioxo-lanosta-8-en-24→20 lactone( ——— )

Catalog No. M38494 CAS No. ———

(3β,7β)-3,7,20,21-Tetrahydroxy-11,15-dioxo-lanosta-8-en-24→20 lactone

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
25MG	Get Quote	Get Quote
50MG	Get Quote	Get Quote
100MG	Get Quote	Get Quote
200MG	Get Quote	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

(3β,7β)-3,7,20,21-Tetrahydroxy-11,15-dioxo-lanosta-8-en-24→20 lactone
Note

Research use only, not for human use.
Brief Description

(3β,7β)-3,7,20,21-Tetrahydroxy-11,15-dioxo-lanosta-8-en-24→20 lactone
Description

(3β,7β)-3,7,20,21-Tetrahydroxy-11,15-dioxo-lanosta-8-en-24→20 lactone
In Vitro

———
In Vivo

———
Synonyms

———
Pathway

Others
Target

Other Targets
Recptor

———
Research Area

———
Indication

———

Chemical Information

CAS Number

———
Formula Weight

———
Molecular Formula

———
Purity

>98% (HPLC)
Solubility

———
SMILES

———
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Tertiapin LQ

Blocker of Kir1.1 channels; displays >250-fold selectivity for Kir1.1 (Kd values are 1.1, 274 and 361 nM for Kir1.1, Kir3.1/3.2 and Kir3.1/3.4 respectively). Derivative of tertiapin-Q.
Talatisamine

Talatisamine (12 μM) and TEA (5mM) inhibits the enhanced I(K) caused by Aβ4 oligomers, attenuates cytotoxicity of Aβ oligomers by restoring cell viability and suppressing K(+) loss related apoptotic response.
16-Acetoxylsugiol

16-Acetoxylsugiol

Sign In Join Free